Asset
APITEGROMAB
Scholar Rock Holding Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03921528 | phase2 | completed | 2019-04-22 | 2021-01-19 | Scholar Rock, Inc. | An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy |
FDA applications (0)
This company has no applications containing this asset.